Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,830 | -30,101 | -128,376 | -17,416 | -126,780 |
| Depreciation Amortization | 1,715 | 3,577 | 3,211 | 12,679 | 4,024 |
| Other Working Capital | -10,689 | -29,223 | 26,974 | 109,570 | -3,719 |
| Other Operating Activity | 14,093 | -98,609 | 14,538 | 12,882 | 12,568 |
| Operating Cash Flow | $-36,711 | $-154,356 | $-83,653 | $117,715 | $-113,907 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,985 | 38,850 | -31,477 | 119,215 | 2,360 |
| PPE Investments | 707 | 1,479 | -6,426 | -1,362 | -1,754 |
| Investing Cash Flow | $-4,278 | $40,329 | $-37,903 | $117,853 | $606 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -292 | -415 | -236 | N/A | N/A |
| Common Stock Issued | 146 | 332 | 2,830 | 4,717 | 5,673 |
| Other Financing Activity | 0 | 0 | -273 | -994 | 0 |
| Financing Cash Flow | $-146 | $-83 | $2,321 | $3,723 | $5,673 |
| Beginning Cash Position | 75,742 | 188,170 | 307,405 | 68,114 | 175,742 |
| End Cash Position | 34,607 | 74,060 | 188,170 | 307,405 | 68,114 |
| Net Cash Flow | $-41,135 | $-114,110 | $-119,235 | $239,291 | $-107,628 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,711 | -154,356 | -83,653 | 117,715 | -113,907 |
| Capital Expenditure | -43 | -661 | -6,426 | -1,362 | -1,754 |
| Free Cash Flow | -36,754 | -155,017 | -90,079 | 116,353 | -115,661 |